FDA Looking At Genetic Factors In Vaccine Safety With New Research Group
Executive Summary
FDA's latest target in its genomics research is vaccine safety, with a new effort to investigate how genetics contribute to vaccine reactions. The agency has hired staff and started work on strategic plans for a new, dedicated team within the Center for Biologics Evaluation and Research